Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Tiling

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|June 14, 2002
[Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer]G Pöpperl, S Lang, O Dagdelen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 4, 2001
Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinomaF Moog, R Linke, N Manthey, et al.
Onkologie|March 8, 2003
Breast cancer: monitoring response to neoadjuvant chemotherapy using Tc-99m sestamibi scintimammographyR Tiling, M Kessler, M Untch, et al.
Journal of Computer Assisted Tomography|March 2, 1999
Whole-body bone marrow MRI in patients with metastatic disease to the skeletal systemM M Steinborn, A F Heuck, R Tiling, et al.
Journal of Computer Assisted Tomography|July 1, 1989
MR imaging of pediatric cardiac tumors previously diagnosed by echocardiographyR Rienmüller, J L Lloret, R Tiling, et al.
European Journal of Nuclear Medicine|July 7, 2001
18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative studyR Tiling, R Linke, M Untch, et al.
Nuklearmedizin. Nuclear Medicine|July 12, 2002
[Breast scintigraphy using 99mTc-sestamibi--use and limitations]R Tiling, R Linke, M Kessler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1997
Comparison of technetium-99m-sestamibi scintimammography with contrast-enhanced MRI for diagnosis of breast lesionsR Tiling, H Sommer, M Pechmann, et al.
Nuklearmedizin. Nuclear Medicine|March 30, 2007
Influence of PET/CT-introduction on PET scanning frequency and indications. Results of a multicenter studyH Stergar, A Bockisch, S M Eschmann, et al.
Der Radiologe|March 25, 2010
[Quantification of immunohistochemical expression of somatostatin receptors in neuroendocrine tumors using 68Ga-DOTATATE PET/CT]A R Haug, G Assmann, C Rist, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|June 14, 2002
[Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer]G Pöpperl, S Lang, O Dagdelen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 4, 2001
Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinomaF Moog, R Linke, N Manthey, et al.
Onkologie|March 8, 2003
Breast cancer: monitoring response to neoadjuvant chemotherapy using Tc-99m sestamibi scintimammographyR Tiling, M Kessler, M Untch, et al.
Journal of Computer Assisted Tomography|March 2, 1999
Whole-body bone marrow MRI in patients with metastatic disease to the skeletal systemM M Steinborn, A F Heuck, R Tiling, et al.
Journal of Computer Assisted Tomography|July 1, 1989
MR imaging of pediatric cardiac tumors previously diagnosed by echocardiographyR Rienmüller, J L Lloret, R Tiling, et al.
European Journal of Nuclear Medicine|July 7, 2001
18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative studyR Tiling, R Linke, M Untch, et al.
Nuklearmedizin. Nuclear Medicine|July 12, 2002
[Breast scintigraphy using 99mTc-sestamibi--use and limitations]R Tiling, R Linke, M Kessler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1997
Comparison of technetium-99m-sestamibi scintimammography with contrast-enhanced MRI for diagnosis of breast lesionsR Tiling, H Sommer, M Pechmann, et al.
Nuklearmedizin. Nuclear Medicine|March 30, 2007
Influence of PET/CT-introduction on PET scanning frequency and indications. Results of a multicenter studyH Stergar, A Bockisch, S M Eschmann, et al.
Der Radiologe|March 25, 2010
[Quantification of immunohistochemical expression of somatostatin receptors in neuroendocrine tumors using 68Ga-DOTATATE PET/CT]A R Haug, G Assmann, C Rist, et al.
Pageof 4